Literature DB >> 33456708

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy.

Adam M Sonabend, Roger Stupp, Catalina Lee-Chang, Hideho Okada.   

Abstract

Entities:  

Keywords:  glioblastoma; glioma; immunoediting; immunotherapy; resistance

Year:  2021        PMID： 33456708      PMCID： PMC7800771          DOI： 10.18632/oncotarget.27865

Source DB:  PubMed          Journal:  Oncotarget        ISSN： 1949-2553


× No keyword cloud information.
  13 in total

Review 1.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

2.  Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.

Authors:  Irene Appolloni; Francesco Alessandrini; Davide Ceresa; Daniela Marubbi; Eleonora Gambini; Daniele Reverberi; Fabrizio Loiacono; Paolo Malatesta
Journal:  Cancer Lett       Date:  2018-10-09       Impact factor: 8.679

3.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.

Authors:  Anoop P Patel; Itay Tirosh; John J Trombetta; Alex K Shalek; Shawn M Gillespie; Hiroaki Wakimoto; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; David N Louis; Orit Rozenblatt-Rosen; Mario L Suvà; Aviv Regev; Bradley E Bernstein
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

4.  Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.

Authors:  Christine E Brown; Darya Alizadeh; Renate Starr; Lihong Weng; Jamie R Wagner; Araceli Naranjo; Julie R Ostberg; M Suzette Blanchard; Julie Kilpatrick; Jennifer Simpson; Anita Kurien; Saul J Priceman; Xiuli Wang; Todd L Harshbarger; Massimo D'Apuzzo; Julie A Ressler; Michael C Jensen; Michael E Barish; Mike Chen; Jana Portnow; Stephen J Forman; Behnam Badie
Journal:  N Engl J Med       Date:  2016-12-29       Impact factor: 91.245

Review 5.  Cancer immunoediting in malignant glioma.

Authors:  Gavin P Dunn; Peter E Fecci; William T Curry
Journal:  Neurosurgery       Date:  2012-08       Impact factor: 4.654

6.  A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

Authors:  Donald M O'Rourke; MacLean P Nasrallah; Arati Desai; Jan J Melenhorst; Keith Mansfield; Jennifer J D Morrissette; Maria Martinez-Lage; Steven Brem; Eileen Maloney; Angela Shen; Randi Isaacs; Suyash Mohan; Gabriela Plesa; Simon F Lacey; Jean-Marc Navenot; Zhaohui Zheng; Bruce L Levine; Hideho Okada; Carl H June; Jennifer L Brogdon; Marcela V Maus
Journal:  Sci Transl Med       Date:  2017-07-19       Impact factor: 17.956

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.

Authors:  Nabil Ahmed; Vita Brawley; Meenakshi Hegde; Kevin Bielamowicz; Mamta Kalra; Daniel Landi; Catherine Robertson; Tara L Gray; Oumar Diouf; Amanda Wakefield; Alexia Ghazi; Claudia Gerken; Zhongzhen Yi; Aidin Ashoori; Meng-Fen Wu; Hao Liu; Cliona Rooney; Gianpietro Dotti; Adrian Gee; Jack Su; Yvonne Kew; David Baskin; Yi Jonathan Zhang; Pamela New; Bambi Grilley; Milica Stojakovic; John Hicks; Suzanne Z Powell; Malcolm K Brenner; Helen E Heslop; Robert Grossman; Winfried S Wels; Stephen Gottschalk
Journal:  JAMA Oncol       Date:  2017-08-01       Impact factor: 31.777

9.  Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.

Authors:  Hirokazu Matsushita; Matthew D Vesely; Daniel C Koboldt; Charles G Rickert; Ravindra Uppaluri; Vincent J Magrini; Cora D Arthur; J Michael White; Yee-Shiuan Chen; Lauren K Shea; Jasreet Hundal; Michael C Wendl; Ryan Demeter; Todd Wylie; James P Allison; Mark J Smyth; Lloyd J Old; Elaine R Mardis; Robert D Schreiber
Journal:  Nature       Date:  2012-02-08       Impact factor: 49.962

Review 10.  The possibility of cancer immune editing in gliomas. A critical review.

Authors:  Víctor A Arrieta; Bernardo Cacho-Díaz; Junfei Zhao; Raul Rabadan; Li Chen; Adam M Sonabend
Journal:  Oncoimmunology       Date:  2018-04-09       Impact factor: 8.110
View more
  1 in total

1.  Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment.

Authors:  Xiangming Cai; Feng Yuan; Junhao Zhu; Jin Yang; Chao Tang; Zixiang Cong; Chiyuan Ma
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.